Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications 3.0
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 26056
Special Issue Editor
Interests: organic chemistry; medicinal chemistry; biotransformations; natural products; plant chemical profile; sustainable chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Seaweed is a natural resource that has been gaining value due to its potential use in pharmaceutical, cosmetics, and food production. Naturally, academic research to establish that these applications are safe and recommended is welcomed, in particular by the final consumer. One of the most critical aspects of this research is demonstrating the relationship between seaweed properties and their secondary metabolites.
The prior Special Issues on seaweed secondary metabolites and their therapeutic applications have been a success. We think that more and more researchers are investing in this area, so most probably, more exciting results are being achieved. Therefore, a third Special Issue of Marine Drugs entitled "Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications 3.0" makes sense.
As Guest Editor, I am inviting scientists to submit their latest research findings, review articles in this area, and contribute high-quality manuscripts exploring bioactive compounds from seaweeds and their therapeutic applications.
Prof. Dr. Diana Cláudia Pinto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Seaweed
- Secondary Metabolites
- Biological Activities
- Algae
- Nutritional Supplements
- Polysaccharides
- Antioxidants
- Fucoidan
- Drug Delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.